Related references
Note: Only part of the references are listed.COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation
Joshua K. Salabei et al.
HEART & LUNG (2021)
A Structure Based Study of Selective Inhibition of Factor IXa over Factor Xa
Sibsankar Kundu et al.
MOLECULES (2021)
A 78-Year-Old Man with a Pulmonary Embolism Who Developed Skin Necrosis 7 Days After Treatment with the Direct Oral Anticoagulant Factor Xa Inhibitor Apixaban
Tusharkumar Pansuriya et al.
AMERICAN JOURNAL OF CASE REPORTS (2021)
Innovative Three-Step Microwave-Promoted Synthesis of N-Propargyltetrahydroquinoline and 1,2,3-Triazole Derivatives as a Potential Factor Xa (FXa) Inhibitors: Drug Design, Synthesis, and Biological Evaluation
Fabian Santana-Romo et al.
MOLECULES (2020)
COVID-19 update: Covid-19-associated coagulopathy
Richard C. Becker
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study
Filippo Albani et al.
ECLINICALMEDICINE (2020)
C-halogen ... pi interactions in nucleic acids: a database study
Debarghya Mitra et al.
JOURNAL OF CHEMICAL SCIENCES (2020)
One-Pot CuO-Catalyzed Green Synthesis of N(N′)-Arylbenzamidines as Potential Enzyme Inhibitors
M. B. Taj et al.
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY (2019)
The Green ChemisTREE: 20 years after taking root with the 12 principles
Hanno C. Erythropel et al.
GREEN CHEMISTRY (2018)
Halogen bonding for the design of inhibitors by targeting the S1 pocket of serine proteases
Longguang Jiang et al.
RSC ADVANCES (2018)
Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management
Ka-Shing Cheung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors
Daniel Verhoef et al.
NATURE COMMUNICATIONS (2017)
Contemporary developments in the discovery of selective factor Xa inhibitors: A review
Nirav R. Patel et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Copper Nanoparticles in Click Chemistry
Francisco Alonso et al.
ACCOUNTS OF CHEMICAL RESEARCH (2015)
Direct Oral Anticoagulants New Drugs and New Concepts
Jerrold H. Levy et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2014)
Copper-Catalyzed Synthesis of lndoles and Related Heterocycles in Renewable Solvents
Stefan G. Koenig et al.
ACS SUSTAINABLE CHEMISTRY & ENGINEERING (2014)
Click Chemistry for Drug Development and Diverse Chemical-Biology Applications
Prakasam Thirumurugan et al.
CHEMICAL REVIEWS (2013)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Peptide Conjugation via CuAAC 'Click' Chemistry
Abdullah A. H. Ahmad Fuaad et al.
MOLECULES (2013)
Fundamentals of green chemistry: efficiency in reaction design
Roger A. Sheldon
CHEMICAL SOCIETY REVIEWS (2012)
2-Methyltetrahydrofuran (2-MeTHF): A Biomass-Derived Solvent with Broad Application in Organic Chemistry
Vittorio Pace et al.
CHEMSUSCHEM (2012)
The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: a patent review
Donald J. P. Pinto et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Profiling the Structural Determinants for the Selectivity of Representative Factor-Xa and Thrombin Inhibitors Using Combined Ligand-Based and Structure-Based Approaches
Shome S. Bhunia et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Click chemistry from organic halides, diazonium salts and anilines in water catalysed by copper nanoparticles on activated carbon
Francisco Alonso et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2011)
Tricks with clicks: modification of peptidomimetic oligomers via copper-catalyzed azide-alkyne [3+2] cycloaddition
Justin M. Holub et al.
CHEMICAL SOCIETY REVIEWS (2010)
Factor Xa Inhibitors: Next-Generation Antithrombotic Agents
Donald J. P. Pinto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Evidence for C-Cl/C-Br center dot center dot center dot pi Interactions as an Important Contribution to Protein-Ligand Binding Affinity
Hans Matter et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa
Donald J. P. Pinto et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide (BAY 59-7939):: An oral, direct factor Xa inhibitor
S Roehrig et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Probing the subpockets of factor Xa reveals two binding modes for inhibitors based on a 2-carboxyindole scaffold:: A study combining structure-activity relationship and X-ray crystallography
M Nazaré et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Co-crystal structure and inhibition of factor Xa by PD0313052 identifies structurally stabilized active site residues of factor Xa and prothrombinase
WR Gould et al.
BIOCHEMISTRY (2005)
1,2,3-triazole as a peptide surrogate in the rapid synthesis of HIV-1 protease inhibitors
A Brik et al.
CHEMBIOCHEM (2005)
Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening
TA Halgren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
A microwave-assisted click chemistry synthesis of 1,4-disubstituted 1,2,3-triazoles via a copper(I)-catalyzed three-component reaction
P Appukkuttan et al.
ORGANIC LETTERS (2004)
Structure-based design of novel guanidine/benzamidine mimics: Potent and orally bioavailable factor Xa inhibitors as novel anticoagulants
PYS Lam et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
How root-mean-square distance (r.m.s.d.) values depend on the resolution of protein structures that are compared
O Carugo
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2003)
Crystal structures of two potent nonamidine inhibitors bound to factor Xa
M Adler et al.
BIOCHEMISTRY (2002)
Share Paper
